Chemours Co - 8-K Filing
Chemours reports Q3 2026 net income of $196 million ($1.29 per diluted share), up from $46 million in the prior-year quarter. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $CC
Read the full article at SEC EDGAR
Part of the story Manulife Reports Record Core Earnings and Strong Asian Growth in Q3 2026 (106 articles)